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The aqueous N-phosphorylation and
N-thiophosphorylation of aminonucleosides†
Louis P. Conway, Richard J. Delley, Jonathan Neville, Gemma R. Freeman,
Hannah J. Maple, Vincent Chan, Alexander J. Hall and David R. W. Hodgson*
We demonstrate N-phosphorylation and N-thiophosphorylation of unprotected aminonucleosides in
aqueous media. N-Phosphorylations using phosphoric chloride and N-thiophosphorylations using
thiophosphoryl chloride were explored as functions of pH using 50-amino-50-deoxyguanosine as
substrate. These reagents were compared to phosphodichloridate and thiophosphodichloridate ions,
and the methodology was applied to other aminonucleosides. S-Alkylations of the nucleoside
N-thiophosphoramidates were investigated as functions of pH and alkylating agent.
Introduction
Nucleoside phosphates are ubiquitous in living systems, with
nucleic acids, adenosine triphosphate, and nucleotide sugars
being key examples. The synthesis of analogues of these
compounds in which the phosphate groups have been modied
has been widely explored.1–4 Phosphate-modied nucleotides
have a number of applications, including investigations of the
roles of phosphate in the binding of nucleoside mono-
phosphates to enzymes.5,6 Modied nucleosides and nucleo-
tides also oﬀer reactive functionalites for bioconjugation.7–10
Standard methods for the synthesis of nucleoside phosphates,
such as the Poulter11 and Yoshikawa12 syntheses, are frequently
cumbersome, and require rigorously dry conditions and labo-
rious purication. The use of the phosphoramidite method,
while highly eﬃcient for the synthesis of oligonucleotides when
the protected nucleoside phosphoramidites are commercially
available, becomes more laborious and requires global protec-
tion and rigorously dry conditions where the de novo syntheses
of non-standard phosphoramidites are required.13
These problemsmotivated us to nd a simple method for the
synthesis of analogues of nucleoside monophosphates and
phosphodiesters, building on our previous work in the area.14–16
Whilst previous syntheses of the 50-N-phosphoramidates of
guanosine17 and other nucleosides5,6,18 have been reported,
these methods suﬀer from similar drawbacks to the Yoshikawa
synthesis. The issues centre on poor nucleoside solubility and
the need for dry conditions. In contrast, we nd that the
aqueous phosphorylation method is more convenient, where a
nucleophilic aminonucleoside allowed phosphorylation to be
carried out in water, with high conversion, and good N-selec-
tivity.14,15 The methodology was extended to the use of thio-
phosphoryl chloride as a (thio)phosphorylation agent on a
series of generic amines, with the advantage that the thio-
phosphoramidates thus formed can then be S-alkylated to
produce analogues of phosphodiester systems.19
Here we seek to explore, expand and optimise the aqueous
phosphorylations and thiophosphorylations of aminonucleo-
sides through pH control, and to compare phosphorylating and
thiophosphorylating agents. We have also previously reported
on the hydrolysis kinetics of phosphodichloridate (Cl2OPO
)
and thiophosphodichloridate (Cl2SPO
) ions,20 and here we
assess their suitability as phosphorylating agents, compared to
their counterparts POCl3 and PSCl3.
Results and discussion
pH control and optimisation
50-Amino-50-deoxyguanosine 3 21 was used as a model substrate
to determine pH optima for phosphorylation procedures. The
50-amino-50-deoxyguanosine 3 was dissolved in water and
adjusted to a predetermined pH value with potassium
hydroxide solution. A single equivalent of the phosphorylating
agent in acetonitrile was then added slowly to the solution
whilst the pH was kept constant using an autotitrator to add
potassium hydroxide solution as required.
The 50-amino-50-deoxyguanosine 3 was either phosphory-
lated or thiophosphorylated using one of phosphoryl chloride
1(O), thiophosphoryl chloride 1(S), potassium phosphodi-
chloridate 2(O) or potassium thiophosphodichloridate 2(S) at
pH values of 11, 11.5, 12, and 12.5 (Fig. 1). Aer addition of the
phosphorylating/thiophosphorylating agent, the conversion
levels were determined by 31P NMR spectroscopy. The N-phos-
phoramidate and N-thiophosphoramidate monoesters are
unstable, except at high pH,14,22,23 making them diﬃcult to
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isolate, however, 50-amino-50-deoxyguanosine 50-N-phosphor-
amidate has been isolated and characterised by 31P NMR and 1H
NMR spectroscopies, and these data were used to corroborate
the observed signals.14 The presence of the N-thiophosphor-
amidate was conrmed by trapping this reactive species
through S-alkylation and isolating and characterising the stable
adduct, in a manner analogous to our earlier report.22
Apart from the desired N-phosphoramidate 5 and N-thio-
phosphoramidate 8, we also observed the formation of bis-
aminolysis side products 6 and 9, in which the phosphorylating
agent was attacked by two equivalents of amine, and inorganic
phosphate 7 and thiophosphate 10, which result from the
breakdown of the phosphorylating agents. These results mimic
those we have seen previously for a range of generic amines 4
(Scheme 1).19,22
The results show optima at pH 12 for each of the four (thio)
phosphorylating agents 1(O), 1(S), 2(O) and 2(S) (Fig. 2). The
Fig. 1 The phosphosphorylating agents 1 and 2 used in this study, and
the model substrate, 50-amino-50-deoxyguanosine 3.
Scheme 1 The observed products and side-products of the phosphorylation and thiophosphorylation reactions. R ¼ 50-deoxyguanosyl.
Fig. 2 The results of the N-phosphorylations and N-thiophosphorylations of 50-amino-50-deoxyguanosine. Notation: (red) product; (green)
inorganic thiophosphate; (blue) inorganic phosphate; (yellow) bis product; (black) other.
38664 | RSC Adv., 2014, 4, 38663–38671 This journal is © The Royal Society of Chemistry 2014
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optima were especially pronounced for the thiophosphorylation
reactions; the greatest levels of conversion were achieved using
the thiophosphodichloridate ion 2(S), with a maximum of 97%
conversion to thiophosphoramidate 8 at pH 12, as opposed to
87% at pH 11. The thiophosphorylation reactions with thio-
phosphoryl chloride 1(S) reect the same trend, with a
maximum of 93% at pH 12, and minimum of 79% at pH 11.
The eﬀect of pH on the oxyphosphorylation appears to be
less pronounced. The greatest level of conversion was again
achieved using the phosphodichloridate ion 2(O) at pH 12, with
83% to 76% being observed over the tested pH range. The
reactions with phosphoryl chloride 1(O) were marginally poorer
with conversions in the range 80% to 72%. Analysis of the by-
products revealed a clear advantage to the use of the phos-
phodichloridate 2(O), namely, the lack of formation of bis
aminolysis product 6.
Considering the structure of the substrate, 50-amino-50-
deoxyguanosine 3 and the (thio)phosphorylating agents, several
factors could account for these trends. High pHs are required to
stabilise the (thio)phosphoramidate products, however, they
also serve to solubilise the 50-amino-50-deoxyguanosine 3
substrate through ionisation of the N–H of the guanine. At
higher pHs, the ionisation of the cis-diol functionality could
contribute to a change in reaction outcome (pKa 12.5).24 In the
case of the dichloridate ions 2(O) and 2(S), hydroxide-promoted
hydrolysis of the (thio)phosphorylating agent is unlikely in light
of our previous studies upon these species, which reveal at
pH–kobs proles.20 With trichlorides 1(O) and 1(S), their
enhanced reactivity could render them more susceptible to
hydrolysis, however, their hydrolysis products are the
dichloridates 2(O) and 2(S), which permit additional opportu-
nity for nucleophilic attack (loss of the “third” chloride is likely
to be unselective towards the nature of the nucleophile, and
thus would reect nucleophile concentration, where water is
clearly the most abundant entity). Solubility phenomena and
the partitioning of reaction partners between diﬀerent phases
could also inuence reaction outcome signicantly, however,
the eﬀects of these properties are diﬃcult to predict.
Synthesis of other aminonucleosides
Having established a single pH optimum across all four phos-
phorylating agents 1(O), 1(S), 2(O) and 2(S) using the model
substrate 50-amino-50-deoxyguanosine 3, we applied the meth-
odology to other nucleosides. Four aminonucleosides were
prepared to test the generality of our nding: 50-amino-50-
deoxyadenosine 11, 30-amino-30-deoxythymidine 12, 50-amino-
50-deoxyuridine 15 and 50-amino-50-deoxycytidine 20. The
dihydrochloride salt of 50-amino-50-deoxyadenosine 11 was
synthesised according to a literature method.25 The 30-amino-30-
deoxy analogue of thymidine 12 was synthesised starting from
the commercially available 30-azido-30-deoxythymidine (AZT),
based on a procedure by Pastor-Anglada et al.26 and was
precipitated as a hydrochloride salt 12$HCl.
50-Amino-50-deoxyuridine was formed by adapting a single
step procedure developed by Hata et al. to convert uridine to 50-
azido-50-deoxyuridine 14,27 which was reduced to the desired
amine using triphenylphosphine,26 and isolated as its hydro-
chloride salt 15$HCl (Scheme 2).
To our knowledge 50-amino-50-deoxycytidine 20 has not been
reported. We protected the exocyclic amino group of cytosine 16
via benzoylation.28 The protection of the 20- and 30-hydroxyl
groups and the tosylation of the 50-hydroxyl group were adapted
from procedures developed by Winans and Bertozzi.29 The
crude tosylated material was reacted with sodium azide in
DMSO in an adapted literature procedure30 to aﬀord azide 18
which was isolated by precipitation in a large volume of water.
The protecting groups were removed,31 and 50-azide 19 was
isolated by cation exchange chromatography. The azide was
then reduced with triphenylphosphine26 and the amine was
isolated as the dihydrochloride salt 20$2HCl (Scheme 3).
Scheme 2 The synthesis of 50-amino-50-deoxyuridine, hydrochloride
salt 15$HCl. Reagents and conditions: (a) Ph3P, CBr4, LiN3, DMF, 4 h, rt;
(b) (i) Ph3P, pyridine, 2 h, rt; (ii) EtOH, HCl(g).
Scheme 3 The synthesis of 50-amino-50-deoxycytidine, dihydrochloride salt 20$2HCl. Reagents and conditions: (a) (i) benzoic anhydride, MeOH,
5 h, reﬂux; (ii) 2,2-dimethoxypropane, TsOH, 4 A˚ mol sieves, DMF, 2 h, 40 C; (b) (i) Ts2O, pyridine, CH2Cl2, 2.5 h, reﬂux; (ii) NaN3, DMSO, 2 h 20
min, 70 C; (c) (i) MeOH, NH4OH, 18 h, rt; (ii) triﬂuoroacetic acid, H2O, 3 h, rt; (iii) ion exchange chromatography; (d) (i) Ph3P, pyridine, 3 h, rt; (ii)
EtOH, HCl(g).
This journal is © The Royal Society of Chemistry 2014 RSC Adv., 2014, 4, 38663–38671 | 38665
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Aminonucleoside phosphorylations and
thiophosphorylations
The thiophosphorylations were carried out using both thio-
phosphoryl chloride 1(S) and thiophosphodichloridate 2(S) on
50-amino-50-deoxyadenosine 11, 50-amino-50-deoxycytidine 20,
30-amino-30-deoxythymidine 12, and 50-amino-50-deoxyuridine
15. The oxyphosphorylations were performed using both oxy-
phosphorylating agents 1(O) and 2(O) on 50-amino-50-deoxy-
adenosine 11 and 30-amino-30-deoxythymidine 12. In every case,
one equivalent of phosphorylating agent was used, and the
phosphorylations were performed at pH 12, based on the nd-
ings of our optimisation experiments (Scheme 4).
The conversion levels observed in the experiments are shown
in Fig. 3. For the thiophosphorylations, conversions were
generally high, especially for the reactions of 50-amino-50-deoxy-
guanosine 3 with thiophosphodichloridate 2(S) and 50-amino-50-
deoxyadenosine 11 with thiophosphoryl chloride 1(S), with
conversions of 97% and 99% respectively. A notable exception
to the high thiophosphorylation conversions is the reaction
with 30-amino-30-deoxythymidine 12; this is likely due to the
more sterically hindered environment of the 30-amine nucleo-
phile in this example.
The use of thiophosphoryl chloride 1(S) gave greater levels of
conversion than the thiophosphodichloridate ion 2(S), with the
exception of the reaction with 50-amino-50-deoxyguanosine 3.
Unlike the thiophosphodichloridate ion, thiophosphoryl chlo-
ride shows very limited solubility in water. This may give rise to
the improved selectivity, despite thiophosphoryl chloride's
greater reactivity, possibly through reaction at solvent–water
interfaces rather than in homogeneous solution.
In other cases, the use of potassium thiophosphodi-
chloridate 2(S) aﬀorded fewer side-products such as the bis
thiophosphoramidate 9. For the oxyphosphorylating agents
1(O) and 2(O), the trend appears to be reversed; the phospho-
dichloridate 2(O) reactions tended to give the greatest levels of
conversion, possibly due to the reduced reactivity of 2(O)
allowing better mixing and thus greater selectivity than with
phosphoryl chloride 1(O). In general, the levels of conversion
for the oxyphosphorylations are more modest than those of the
thiophosphorylations with a maximum of 83% for the reaction
of 50-amino-50-deoxyguanosine 3 with phosphodichloridate
2(O). 30-Amino-30-deoxythymidine again showed the poorest
conversions, at 44% and 51% for the reactions with phosphor-
ylating agents 1(O) and 2(O) respectively.
Thiophosphoramidate S-alkylation
The S-Alkylation of thiophosphoramidates 21a–d(S) could
provide access to mimics of naturally occurring phospho-
diesters such as CMP-Neu5Ac or analogues for mechanistic
studies.4 Additionally, there are many commercially available
alkylating agents, and this reaction could allow the rapid
Fig. 3 Conversion levels for the N-phosphorylations and N-thiophosphorylations of 50-amino-50-deoxyguanosine 3, 50-amino-50-deoxy-
adenosine 11, 30-amino-30-deoxythymidine 12, 50-amino-50-deoxyuridine 15, and 50-amino-50-deoxycytidine 20.
Scheme 4 The N-phosphorylations and N-thiophosphorylations of
50-amino-50-deoxyadenosine 11, 30-amino-30-deoxythymidine 12,
50-amino-50-deoxyuridine 15, and 50-amino-50-deoxycytidine 20.
38666 | RSC Adv., 2014, 4, 38663–38671 This journal is © The Royal Society of Chemistry 2014
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development of a diverse range of derivatives. We conducted
preliminary studies in this vein recently, where the products of
the N-thiophosphorylation-S-alkylation of 50-amino-50-deoxy-
guanosine 3 and 50-amino-50-deoxyadenosine 11 were prepared
and isolated from non-pH-controlled reactions, and these
results served as our starting point.22Here we investigate the pH
optimisation of this procedure. Using our model substrate, 50-
amino-50-deoxyguanosine 3, we performedN-thiophosphorylation,
and the resulting nucleoside-N-thiophosphoramidate anion
was then S-alkylated with one of three alkylating agents, each at
xed pHs using an autotitrator (Scheme 5).
We chose benzyl chloride, methyl iodide, and 2-bromoethanol
as alkylating agents, using guanosine-N-thiophosphoramidate
4(S) as the substrate. Guanosine-N-thiophosphoramidate 4(S) was
prepared under optimised conditions, where >95% of the product
represented the desired material, and this material was used
directly in S-alkylation procedures. The conversion levels deter-
mined by 31P NMR spectroscopy for each of the alkylating agents
at each pH are illustrated in Fig. 4.
To conrm the intermediacy of the unstable, unalkylated
precursor N-thiophosphoramidate 4(S), three S-alkylation
experiments were performed on 4(S) at pH 12, and the products
were isolated by ion exchange chromatography and charac-
terised. Isolated yields of 95%, 63%, and 74% were recorded for
the S-methyl 22a, benzyl 22b, and ethan-2-ol 22c systems.
S-Alkylation eﬃciency appeared to be largely unaﬀected by pH,
at least within the range that we studied, with conversions levels
being 80%. Surprisingly, S-alkylation occurs at lower conver-
sion levels than N-thiophosphorylation, which may be due, in
part, to the hydrolysis of the desired products under the high
pH conditions. In particular, the formation of a nascent “good”
thiolate leaving group through S-alkylation could represent a
likely pathway for hydrolysis, and we are currently studying the
hydrolysis kinetics of the S-alkylated thiophosphoramidates to
give greater insight.
Conclusions
Eﬀective N-oxyphosphorylation and N-thiophosphorylation of
aminonucleosides 3, 11, 12, 15 and 20 was achieved through pH
control, with high levels of conversion. Phosphodichloridates
2(O) and 2(S) were competent alternative phosphorylation
agents, that eliminated the formation of undesired bis-ami-
no(thio)phosphoramidates, while retaining similar levels of
conversion. The S-alkylation of guanosine-N-thiophosphor-
amidate 4(S) showed no signicant pH-sensitivity across the pH
range 9–12, although conversion levels were not quantitative.
The combination of eﬃcient N-(thio)phosphorylation and
S-alkylation gives straightforward access to phosphodiester
mimics from a range of unprotected aminonucleosides derived
from the common nucleobases.
Experimental
N4-Benzoylcytidine
In an adapted literature procedure,28 cytidine (2.784 g, 11.4
mmol) and benzoic anhydride (2.818 g, 12.5 mmol) were placed
in a round bottomed ask with dry methanol (300 ml) and
heated at reux with stirring. Aer 1 h, additional benzoic
anhydride (2.774 g, 12.3 mmol) was added, followed by further
additions (2.785 g, 12.3 mmol aer 2 h, 2.794 g, 12.4 mmol aer
3 h). Heating was maintained for a total of 5 h. Aer allowing
the reaction vessel to cool for 18 h, the precipitate was collected
by vacuum ltration. Drying over P2O5 under vacuum yielded
the desired product (2.786 g, 70%), mp 236–238 C (from
methanol) (lit.,32 238–240 C); nmax/cm
1 3421, 3307, 3161, 1644
(CO); dH (400 MHz, (CD3)2SO) 3.61 (1H, ddd, J 12.3, 5.2, 3.1,
Fig. 4 The conversion levels by 31P NMR spectroscopy of S-alkylations of guanosine-N-thiophosphoramidate 4(S) to S-alkylthiophosphor-
amidates 22a–c using methyl iodide, benzyl chloride, and 2-bromoethanol, respectively.
Scheme 5 The alkylation of 50-deoxyguanosine 50-thiophosphor-
amidate 4(S). Reagents and conditions: (a) MeI to give 22a; (b) BnCl to
give 22b; or bromoethanol to give 22c.
This journal is © The Royal Society of Chemistry 2014 RSC Adv., 2014, 4, 38663–38671 | 38667
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C50-Ha), 3.76 (1H, ddd, J 12.3, 5.2, 2.8, C50-Hb), 3.92 (1H, td, J 5.9,
2.9, C40-H), 3.95–4.05 (2H, m, C20-H, C30-H), 5.05 (1H, d, J 5.7,
C30-OH), 5.18 (1H, app t, J 5.1, C50-OH), 5.51 (1H, d, J 4.8, C20-
OH), 5.81 (1H, d, J 2.9, C10-H), 7.34 (1H, d, J 7.5, C5-H), 7.52 (2H,
dd, J 7.1, 8.4, m-Ph), 7.63 (1H, t, J 7.4, p-Ph), 8.00 (2H, d, J 7.5, o-
Ph), 8.51 (1H, d, J 7.5, C6-H), 11.25 (1H, s, NH); dC (126 MHz,
(CD3)2SO) 60.6, 69.3, 75.3, 84.9, 90.9, 96.6, 110.0, 129.2, 133.5,
133.8, 146.1, 155.4, 163.8, 168.0; m/z 346.2 (M  H, 100%) 347.2
(26) 693 (22).
N4-Benzoyl-20,30-O-isopropylidenecytidine (17)
In an adapted literature procedure,29 N4-benzoylcytidine (2.79 g,
8.03 mmol), 2,2-dimethoxypropane (11 ml), 4 A˚ molecular
sieves, and tosic acid monohydrate (0.45 g, 2.37 mmol) were
placed in a round-bottomed ask with DMF (44 ml). The
mixture was heated at 40 C for 2.5 h, before Amberlyst® A-21
anion exchanger (1.19 g) was added and heating was continued
for a further 30 min. The mixture was ltered through Celite®,
the solvent was then removed under vacuum from the ltrate,
and the residue was recrystallised from water to yield the
product (2.375 g, 76%); mp 163–165 C; nmax/cm
1 1652 (CO),
1482, 1303; dH (400 MHz, CDCl3) 1.37 (3H, s, CH3a), 1.63 (3H, s,
CH3b), 3.54 (1H, br s, C50-OH), 3.80–3.89 (1H, m, C50-Ha), 3.97
(1H, dd, J 12.2, 2.3, C50-Hb), 4.40 (1H, app q, J 3.0, C40-H), 5.09
(1H, dd, J 6.4, 3.3, C30-H), 5.25 (1H, dd, J 6.6, 2.6, C20-H), 5.55
(1H, d, J 2.7, C10-H), 7.52 (2H, d, J 7.8, m-Ph), 7.63 (1H, t, J 7.4,
p-Ph), 7.81 (1H, d, J 7.4, C6-H), 7.89 (2H, d, J 7.5, o-Ph), 8.77 (1H,
s, NH); dC (126 MHz, CDCl3) 25.2, 27.3, 62.9, 80.5, 83.6, 88.1,
99.0, 100.0, 112.8, 114.1, 127.3, 127.6, 128.6, 129.1, 133.4, 143.3,
166.1; m/z 388.1500 (M + H+, 20%), requires 388.1509, 410.1325
(M + Na+, 100).
N4-Benzoyl-20,30-O-isopropylidene-50-O-
toluenesulfonylcytidine
N4-Benzoyl-20,30-O-isopropylidenecytidine (2.10 g, 5.42 mmol),
4-toluenesulfonyl chloride (2.44 g, 12.9 mmol), pyridine (20 ml)
and DCM (40 ml) were placed in a round-bottomed ask and
heated at reux for 2.5 h. The solution was then diluted with
chloroform (120 ml) and washed with hydrochloric acid (0.5 M,
5  50 ml) and saturated sodium hydrogencarbonate solution
(2  50 ml). The organic layer was dried over MgSO4 and the
solvent was removed under vacuum to yield the crude product,
which was used in the next reaction without further purica-
tion. (1.53 g).
50-Azido-50-deoxy-N4-benzoyl-20,30-O-isopropylidenecytidine
(18)
Adapting a literature procedure,30 N4-benzoyl-20,30-O-iso-
propylidene-50-O-toluenesulfonylcytidine (1.08 g, 1.99 mmol)
and sodium azide (579 mg, 8.91 mmol) were placed in a ask
with DMSO (10 ml) and heated at 70 C for 2 h 20 min. The
solution was then added to H2O (550 ml) and le to stir for 18 h.
The precipitated product was then isolated by vacuum ltration.
(430 mg, 52%); mp 163–165 C; nmax/cm
1 3354, 1640 (CO),
1485; dH (400 MHz, CDCl3) 1.37 (3H, s, CH3a), 1.60 (3H, s, CH3b),
3.65 (1H, dd, J 12.8, 4.4, C50-Ha), 3.76, (1H, dd, J 12.8, 6.8,
C50-Hb) 4.31–4.36 (1H, m, C40-H), 4.90 (1H, dd, J 6.4, 4.0, C20-H),
5.11–5.15 (1H, m, C30-H), 5.70 (1H, d, J 1.5, C10-H), 7.53 (2H, t, J
7.6, m-Ph), 7.63 (1H, t, J 7.4, p-Ph), 7.77 (1H, d, J 7.4, C6-H), 7.89
(2H, d, J 7.2, o-Ph), 8.67 (1H, s, NH); dC (100 MHz, D2O) 25.2,
27.3, 62.8, 77.2, 80.5, 83.8, 88.1, 97.0, 98.7, 114.1, 127.7, 129.1,
132.7, 133.4, 147.8, 163.1;m/z 413.1585 (M + H+, 100%), requires
413.1573, 435.1406 (M + Na+, 40%).
50-Azido-50-deoxycytidine (19)
Based on a literature procedure,31 50-Azido-50-deoxy-N4-benzoyl-
20,30-O-isopropylidene cytidine (732 mg, 1.78 mmol) was placed
in a round-bottomed ask with a 1 : 1 mixture of methanol and
concentrated ammonium hydroxide (90 ml) and was stirred at
room temperature for 18 h. The solvents were removed under
vacuum, and the residue was stirred in a 9 : 1 mixture of tri-
uoroacetic acid and H2O for 3 h at room temperature before
the solvents were removed under vacuum. The residue was
dissolved in H2O and introduced to a protonated SP Sepharose®
Fast Flow cation exchange column (1.6 cm i.d.  22 cm, 5 ml
min1 ow rate). The nucleoside was eluted with a 3% ammo-
nium hydroxide solution (diluted from 35% (w/w) ammonium
hydroxide solution) and the eluted fractions were freeze-dried.
The residue was then dissolved in methanol and ltered, and
the solvent was removed from the ltrate under vacuum to give
the solid product. (334 mg, 70%); nmax/cm
1 2104 (N3), 1645
(CO), 1438; dH (400 MHz, D2O) 3.64 (1H, dd, J 13.7, 5.0, C50-Ha),
3.78 (1H, dd, J 13.7, 3.1, C50-Hb), 4.14–4.19 (1H, m, C40-H), 4.21
(1H, dd, J 6.2, 5.3, C30-H), 4.34 (1H, dd, J 5.3, 4.0, C20-H), 5.87
(1H, d, J 4.0, C10-H), 6.03 (1H, d, J 7.5, C5-H), 7.74 (1H, d, J 7.6,
C6-H); dC (100 MHz, D2O) 51.2, 69.9, 73.3, 81.5, 90.5, 96.3, 141.6,
157.4, 163.8; m/z 267.2 (M  H, 100%) 268.3 (15).
50-Amino-50-deoxycytidine, hydrochloride salt (20$2HCl)
50-Azido-50-deoxycytidine (400 mg, 1.49 mmol) was placed in a
ask with triphenylphosphine (790 mg, 3.01 mmol) and pyri-
dine (6 ml). The solution was stirred at room temperature for 3
h before further triphenylphosphine (791 mg, 3.02) and pyri-
dine (6 ml) were added. The solution was stirred for an addi-
tional 3 h at room temperature before ammonia solution (50ml,
35% w/w) was added, whereupon immediate precipitation was
observed. The mixture was stirred overnight before being
diluted with water (100 ml) and extracted with chloroform (3 
100 ml). Residual chloroform was removed from the aqueous
layer under vacuum, and the aqueous extracts were lyophilised.
The resulting solid was dissolved in ethanol (60 ml) and
hydrogen chloride gas was bubbled through the solution. The
addition of diethyl ether (300 ml) precipitated the product,
which was isolated by ltration, washed with a small quantity of
diethyl ether, and dried under vacuum overnight (382mg, 81%);
mp 190–191 C (decomp.) (from ethanol); nmax/cm
1 3118, 3046,
1715, 1673, 1404; dH (400 MHz, D2O) 3.34 (1H, dd, J 13.6, 9.4,
C50-Ha), 3.47 (1H, dd, J 13.6, 3.0, C50-Hb), 4.18–4.31 (2H, m, C30-
H, C40-H), 4.51 (1H, dd, J 3.4, 5.5, C20-H), 5.77 (1H, d, J 3.4, C10-
H), 6.24 (1H, d, J 7.9, C5-H), 7.87 (1H, d, J 7.9, C6-H); dC
(100 MHz, D2O) 41.9, 71.4, 73.5, 80.2, 94.1, 95.8, 137.8, 145.9,
38668 | RSC Adv., 2014, 4, 38663–38671 This journal is © The Royal Society of Chemistry 2014
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160.9; m/z 243.1095 (M + H+, 50%), requires 243.1093, 265.0907
(M + Na+, 100).
30-Amino-30-deoxythymidine, hydrochloride salt (12$HCl)
Adapting a literature procedure,26 30-amino-30-deoxythymidine
(1.00 g, 3.74 mmol) and triphenylphosphine (1.54 g, 5.87 mmol)
were dissolved in pyridine (8 ml) and stirred at room tempera-
ture for 1 h. Ammonia solution (30 ml, 35%) was then added,
and the mixture le to stir overnight. The suspension was
diluted with water (30 ml) and extracted with chloroform (3 
30 ml) before being lyophilised. The solid residue was dissolved
in ethanol (100 ml) and hydrogen chloride gas was bubbled
through the solution until precipitation was observed. The
precipitate was isolated by ltration, and washed with a small
quantity of diethyl ether. Additional product was obtained by
adding diethyl ether (500 ml) to the ltrate, and again ltering
and washing the precipitate. The isolated solids were combined
and dried under vacuum overnight yielding a total of 846 mg,
81%; mp 253–255 C (decomp.) (from ethanol); nmax/cm
1 3392,
3032, 1694, 1644, 1470. dH (400 MHz, D2O) 1.86 (3H, s, C5-CH3),
2.54–2.70 (2H, m, C20-HaHb), 3.81 (1H, dd, J 12.6, 4.6, C50-Ha),
3.89 (1H, dd, J 12.6, 3.4, C50-Hb), 4.06 (1H, dt, J 8.1, 5.5, C30-H),
4.19–4.28 (1H, m, C40-H), 6.25–6.32 (1H, t, J 6.8, C10-H), 7.62 (1H,
d, J 1.1, C6-H); dC (100 MHz, D2O) 10.5, 33.8, 49.1, 59.7, 81.5,
84.1, 110.5, 136.6, 150.5, 165.4; m/z 242.1142 (M + H+, 100%),
requires 242.1141, 264.0961 (M + Na+, 90).
Lithium azide
Following a literature procedure,33 sodium azide (6.52 g, 100
mmol) and lithium sulfate (6.90 g, 62.8 mmol) were co-dissolved
in water (35 ml) and stirred for 10 min. Ethanol (175 ml) was
slowly added, and the mixture was stirred for a further 10 min.
The precipitate was removed by ltration, and the solvent
was removed from the ltrate under vacuum. The solid
residue was dried on the high vacuum line to yield the product
(4.818 g, 98%).
50-Azido-50-deoxyuridine (14)
With somemodications, a literature procedure was followed.27
Uridine (5.00 g, 20.5 mmol), triphenylphosphine (8.05 g,
30.5 mmol), tetrabromomethane (10.2 g, 30.5 mmol), and
lithium azide (3.695 g, 75.5 mmol) were stirred together in DMF
(100 ml) for 4 h at room temperature. The greater part of the
solvent was removed under vacuum, and the residue was
extracted with chloroform (100 ml) and water (100 ml), with the
aqueous layer being retained. The aqueous layer was washed
again with chloroform (2  100 ml) before being lyophilised.
The viscous residue was puried by column chromatography,
using an isocratic 5 : 1 mixture of chloroform and methanol.
The resulting oil was dissolved in 5 : 1 chloroform–methanol
and adsorbed on to a plug of silica, which was washed with
100% chloroform to remove residual DMF, then released using
the 5 : 1 chloroform–methanol solution to yield the puried
product. (3.70 g, 67%); nmax/cm
1 2102 (N3), 1667 (CO), 1462,
1386, 1100 (R2COH); dH (500 MHz, D2O) 3.69 (1H, dd, J 13.7, 5.0,
C50-Ha), 3.82 (1H, dd, J 13.7, 3.2, C50-Hb), 4.18–4.23 (1H, m,
C40-H), 4.27 (1H, app t, J 5.6, C03-H), 4.42 (1H, dd, J 5.4, 4.5, C20-
H), 5.89 (1H, d, J 4.4, C10-H), 5.93 (1H, d, J 8.1, C5-H), 7.80 (1H, d,
J 8.1, C6-H); dC (126 MHz, D2O) 51.6, 70.2, 73.3, 82.3, 90.1, 102.6,
142.2, 151.7, 166.2; m/z 268.0676 (M  H, 30%), requires
268.0682, 304.0408 (100).
50-Amino-50-deoxyuridine, hydrochloride salt (15$HCl)
Adapting a literature procedure,26 50-azido-50-deoxyuridine
(404 mg, 1.50 mmol) and triphenylphosphine were (1.66 g, 6.33
mmol) were dissolved in pyridine (1.6 ml) and stirred for 2 h.
Ammonia solution (35%, 12 ml) was then added, and the
mixture le to stir overnight. Water (40 ml) was added, and the
mixture was extracted with chloroform (3  40 ml). Residual
chloroform was then removed from the aqueous layer under
vacuum, and the remaining solution was lyophilised. The
resulting powder was then dissolved in ethanol (20 ml) and
heated at reux until dissolved. Hydrogen chloride gas was
bubbled through the solution until precipitation occurred, and
the pure hydrochloride salt was isolated by ltration and
washing with a small quantity of ethanol. (329 mg, 78%); mp
210–215 C (decomp.) (from ethanol); nmax/cm
1 3040, 1666
(CO), 1464, 1042; dH (700 MHz, D2O) 3.29–3.36 (1H, m, C50-Ha),
3.44–3.49 (1H, m, C50-Hb), 4.22–4.26 (2H, m, C03-H, C40-H), 4.52
(1H, dd, J 5.2, 4.0, C20-H), 5.77 (1H, d, J 4.0, C10-H), 5.89 (1H, d, J
8.0, C5-H), 7.66 (1H, d, J 8.1, C6-H); dC (126 MHz, D2O) 41.8,
71.4, 73.2, 80.0, 93.3, 102.8, 143.9, 152.0, 166.9; m/z 244.0934
(M  H, 100%), requires 244.0933.
Phosphorylating agents
The preparation of potassium phosphodichloridate and potas-
sium thiophosphodichloridate has been reported previously.20,34
Phosphorylation procedure
The aminonucleoside (0.500 mmol) was placed in a thermo-
stated reaction ask maintained at 25 C and water and
potassium hydroxide were added as required to make a 5 ml
solution at the desired pH. The phosphorylating agent (1.50 ml,
0.333 M in MeCN) was added using a Hamilton® microlitre
syringe. The addition took place over 10 min with vigorous
stirring, and with the tip of the syringe below the surface of the
reaction mixture. Throughout the experiment, the pH was kept
constant using a 1 M solution of potassium hydroxide, added by
the autotitrator system. The experiment was considered to be
complete when the autotitrator needed to add negligible
quantities of potassium hydroxide solution to the reaction
mixture. Aer the completion of the reaction, the organic
solvent was removed under vacuum and aqueous remainder
was lyophilised.
Alkylation procedure
Aqueous solutions (5 ml) of 50-amino-50-deoxyguanosine thio-
phosphoramidate 114 (28.2 mg) were made up in the thermo-
stated reaction ask at a concentration of 20 mM at the desired
pH, and were vigorously stirred at 25 C. Methyl iodide (14.3 ml),
benzyl chloride (26.5 ml) or bromoethanol (12.4 ml) alkylating
This journal is © The Royal Society of Chemistry 2014 RSC Adv., 2014, 4, 38663–38671 | 38669
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agent was then added to the reaction solution via Hamilton®
syringe and stirred for 1 h. The excess alkylating agents were
removed by extraction with diethyl ether (3  10 ml) and the
aqueous solution was subsequently lyophilised. The conver-
sions of 50-amino-50-deoxyguanosine thiophosphoramidate to
alkylated thiophosphoramidate product were estimated by 31P
NMR spectroscopy. Where the products of the alkylation were
isolated, the lyophilised crude material was redissolved in water
(4 ml) and puried by anion exchange chromatography with a
ow rate of 5 ml min1 over a DEAE-Sepharose® resin. Trie-
thylammonium bicarbonate buﬀer was applied in a 0 to 0.15 M
gradient over 200 min. The fractions corresponding to peaks in
the UV-vis absorbance were collected and lyophilised.
50-Amino-50-deoxyguanosine, N-,S-
methylthiophosphoramidate, triethylammonium salt (22a)
Aer purication, a small quantity of by-product (MeSPO3
2,
<10% mol basis by 31P NMR spectroscopy) remained. 47 mg,
95%; dH (400 MHz, D2O) 1.26 (9H, t, J 7.3, HN
+(CH2CH3)3), 2.08
(3H, d, J 13.0, CH3S), 2.94–3.28 (2H, m, C50-H2), 3.18 (6H, q, J 7.3,
HN+(CH2CH3)3), 4.31–4.35 (1H, m, C40-H), 4.41 (1H, app d, J 5.6,
C30-H), 5.08 (1H, dd, J 8.0, 5.6, C20-H), 5.76 (1H, d, J 8.0, C10-H),
7.87 (1H, s, C8-H); dC (101 MHz, D2O) 8.3, 11.4, 43.4, 46.7, 71.4,
86.0, 88.8, 100.0, 117.2, 139.8, 151.3, 153.7, 159.0; dP (162 MHz,
D2O) 26.3;m/z 391.0597 (M Et3NH+, 100%), requires 391.0590,
392.0627 (20), 393.0617 (10).
50-Amino-50-deoxyguanosine, N-,S-
benzylthiophosphoramidate, triethylammonium salt (22b)
Aer the purication procedure, some by-product (BnSPO3
2,
10% mol basis by 31P NMR spectroscopy) remained. 36 mg,
63%; dH (400 MHz, D2O) 1.25 (9H, t, J 7.3, HN
+(CH2CH3)3), 2.80–
3.20 (2H, m, C50-H2), 3.17 (6H, q, J 7.3, HN
+(CH2CH3)3), 3.80–3.88
(2H, m, J 5.6, SCH2Ph), 4.18–4.22 (1H, m, C40-H), 4.33 (1H, dd, J
5.6, 1.6, C30-H), 5.10 (1H, dd, J 7.9, 5.6, C20-H), 5.66 (1H, d, J 7.9,
C10-H) 6.99 (1H, t, J 7.1, o-ph), 7.06 (2H, t, J 7.1,m-ph), 7.24 (2H, d,
J 7.1, o-ph) 7.82 (1H, s, C8-H); dC (101 MHz, D2O) 8.2, 10.5, 43.3,
46.6, 59.0, 70.9, 71.5, 85.7, 88.7, 117.2, 126.6, 128.2, 138.6, 139.9,
151.3, 153.5, 158.9; dP (162 MHz, D2O) 24.1; m/z 467.0899 (M 
Et3NH
+, 100%), requires 467.0903, 468.0936 (20), 469.0919 (10).
50-Amino-50-deoxyguanosine, N-,S-ethan-2-
olthiophosphoramidate, triethylammonium salt (22c)
39 mg, 74%; dH (400 MHz, D2O) 1.35 (9H, t, J 7.3, HN
+(CH2CH3)3),
2.88 (2H, dt, J 12.7, 6.4, SCH2CH2OD), 3.26 (6H, q, J 7.3,
HN+(CH2CH3)3), 3.79 (2H, t, J 6.4, SCH2CH2OD), 4.43 (1H, dd, J 2.9,
1.6, C40-H), 4.50 (1H, dd, J 5.6, 1.6, C30-H), 5.18 (1H, dd, J 8.0, 5.6,
C20-H) 5.86 (1H, d, J 8.0, C10-H), 7.95 (1H, s, C8-H); dC (101 MHz,
D2O) 8.3, 10.6, 31.9, 43.4, 46.7, 61.5, 71.4, 85.9, 88.7, 117.4, 139.4,
151.3, 155.0, 160.5; dP (162 MHz, D2O) 24.9; m/z 421.0679 (M 
Et3NH
+, 100%), requires 421.0695, 422.0733 (20), 443.0501 (10).
Analysis
The solid residues resulting from the experiments were dis-
solved in 750 ml or the minimum volume of D2O, whichever
was less, and analysed by NMR spectroscopy to determine
conversion. The conversion levels were determined using
all the peaks visible by 31P NMR spectroscopy with a relaxa-
tion time of 10 s, acquisition time of 1.28 s, and 128 tran-
sients. 1H NMR spectra were also recorded. The 31P NMR
spectroscopic chemical shis of the phosphoramidate and
thiophosphoramidate products of the reaction were found to
be consistent with those determined in our previous
work.15,19,22 The changes in chemical shis of the 1H NMR
signals corresponding to the 50 or 30 protons (depending on
the substrate) of 0.5 ppm upeld, and the increase in
multiplicity through coupling to phosphorus corroborated
the formation of the desired phosphoramidates and
thiophosphoramidates.
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